Diabetes mellitus is an independent predictor of obstructive coronary artery disease in patients presenting with atrial fibrillation and elevated troponin-Reference-Cited by-同舟云学术

Diabetes mellitus is an independent predictor of obstructive coronary artery disease in patients presenting with atrial fibrillation and elevated troponin

Published:2023-03 Issue:3 Volume:53 Page:436-438
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

Fahey James K.¹^ORCID,Prosser Hamish¹,Lescai Prue¹,Sajeev Jithin K.¹^ORCID,Yao Harrison¹,Roberts Louise¹,Buntine Paul¹²,Teh Andrew W.¹³

Affiliation:

1. Cardiology Department Eastern Health Victoria Melbourne Australia

2. Eastern Health Clinical School Monash University Melbourne Victoria Australia

3. Department of Cardiology, The University of Melbourne Austin Hospital Clinical School Victoria Melbourne Australia

Abstract

AbstractAtrial fibrillation can present with symptoms of myocardial infarction and elevated troponin, even in the absence of obstructive coronary artery disease (CAD). We sought to determine the characteristics that predict underlying obstructive CAD. Obstructive CAD was far more likely in those with troponin elevation. In those with elevated troponin, diabetes mellitus was an independent predictor of obstructive CAD.

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.16027

Reference9 articles.

1. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

2. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

3. Causes of elevated troponin I with a normal coronary angiogram

4. Dynamic high-sensitivity troponin elevations in atrial fibrillation patients might not be associated with significant coronary artery disease

5. Atrial fibrillation-induced cardiac troponin I release